Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.

Company Data

Name Allurion Technologies, Inc. Common Stock

Company Allurion Technologies Inc.

Symbol ALUR

Website https://www.allurion.com

Primary Exchange

NYSE

ISIN US02008G1022

Asset Class Share

Sector Healthcare

Industry Medical - Devices

CEO Shantanu K. Gaur

Market Capitalization 20 Mio

Country United States of America

Currency USD

Employees 0,1 T

Address 11 Huron Drive, 01760 Natick

IPO Date 2021-03-29

Stock Splits

Date	Split
03.01.2025	1:25

Ticker Symbols

Name	Symbol
NYSE	ALUR

More Shares

Investors who hold Allurion Technologies, Inc. Common Stock also have the following shares in their portfolio:

INV.BK.BB IHS 21/31 Bond

K.F.W.ANL.V.06/2037 CD Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog